TCEB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.139700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.539800E-02
Normal-vs-Stage2
5.378000E-02
Normal-vs-Stage3
2.775800E-01
Normal-vs-Stage4
7.095800E-02
Stage1-vs-Stage2
7.727000E-01
Stage1-vs-Stage3
9.487000E-01
Stage1-vs-Stage4
9.736800E-01
Stage2-vs-Stage3
8.990800E-01
Stage2-vs-Stage4
8.443400E-01
Stage3-vs-Stage4
9.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.022100E-02
Normal-vs-AfricanAmerican
9.643800E-02
Normal-vs-Asian
1.861760E-02
Caucasian-vs-AfricanAmerican
6.812200E-01
Caucasian-vs-Asian
1.249990E-02
AfricanAmerican-vs-Asian
8.683600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.170300E-02
Normal-vs-Female
7.355700E-02
Male-vs-Female
2.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.823350E-01
Normal-vs-Age(41-60Yrs)
3.654000E-02
Normal-vs-Age(61-80Yrs)
5.904400E-02
Normal-vs-Age(81-100Yrs)
3.736100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.593600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.092000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.184000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.881800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.122500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.002650E-01
Normal-vs-Daily Drinker
5.063900E-02
Normal-vs-Weekly Drinker
6.270100E-02
Normal-vs-Occasional Drinker
2.034400E-02
Normal-vs-Social Drinker
7.658000E-02
Non Drinker-vs-Daily Drinker
1.752830E-01
Non Drinker-vs-Weekly Drinker
1.716600E-01
Non Drinker-vs-Occasional Drinker
3.934400E-01
Non Drinker-vs-Social Drinker
6.668000E-01
Daily Drinker-vs-Weekly Drinker
8.587400E-01
Daily Drinker-vs-Occasional Drinker
5.936400E-01
Daily Drinker-vs-Social Drinker
1.198570E-01
Weekly Drinker-vs-Occasional Drinker
5.018000E-01
Weekly Drinker-vs-Social Drinker
1.150390E-01
Occasional Drinker-vs-Social Drinker
1.925180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.126800E-01
Normal-vs-Grade 2
5.233800E-02
Normal-vs-Grade 3
9.108200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.266400E-02
Grade 1-vs-Grade 3
3.473200E-01
Grade 1-vs-Grade 4
3.126800E-01
Grade 2-vs-Grade 3
2.152000E-01
Grade 2-vs-Grade 4
5.233800E-02
Grade 3-vs-Grade 4
9.108200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.125820E-01
Normal-vs-NonDiabetic
2.356300E-02
Diabetic-vs-NonDiabetic
1.828010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.977920E-02
Normal-vs-NoPancreatitis
4.563700E-02
Pancreatitis-vs-NoPancreatitis
3.362400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.772100E-02
Normal-vs-N1
6.731600E-02
N0-vs-N1
2.174200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.657700E-02
Normal-vs-TP53-NonMutant
3.486400E-01
TP53-Mutant-vs-TP53-NonMutant
7.44189999957179E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
